γ-oryzanol ameliorates the acute stress induced by behavioral anxiety testing in mice

Salina Akter, Hiroyuki Sasaki, Yuko Ikeda, Hiroki Miyakawa, Shigenobu Shibata

    Research output: Contribution to journalArticle

    Abstract

    We evaluated the anxiolytic effect of γ-oryzanol (GORZ) and elucidated the molecular mechanisms involved in its inhibition of behavioral test-induced anxiety. Behavioral tests were conducted on day 13, and mice were subjected to 30 min of acute restraint stress treatment (ARST) before sacrifice on day 16. In other group, behavioral tests were conducted on day 13 and 14 after ARST. 0.5% GORZ significantly weakened the effect of behavioral stress, but not the effect of strong ARST. GORZ downregulated ARST-induced cFos levels in the cerebral cortex. In conclusion, GORZ has potential ant-anxiety effect in the treatment of weak behavioral test-induced stress.

    Original languageEnglish
    JournalJournal of Pharmacological Sciences
    DOIs
    Publication statusAccepted/In press - 2018 Jan 1

    Fingerprint

    Anxiety
    Ants
    Anti-Anxiety Agents
    Cerebral Cortex
    Down-Regulation
    Behavior Rating Scale
    gamma-oryzanol

    Keywords

    • Anxiety
    • Behavioral tests
    • cFos

    ASJC Scopus subject areas

    • Molecular Medicine
    • Pharmacology

    Cite this

    γ-oryzanol ameliorates the acute stress induced by behavioral anxiety testing in mice. / Akter, Salina; Sasaki, Hiroyuki; Ikeda, Yuko; Miyakawa, Hiroki; Shibata, Shigenobu.

    In: Journal of Pharmacological Sciences, 01.01.2018.

    Research output: Contribution to journalArticle

    @article{02bc55e2f8ef4b6bb951e657c4973c79,
    title = "γ-oryzanol ameliorates the acute stress induced by behavioral anxiety testing in mice",
    abstract = "We evaluated the anxiolytic effect of γ-oryzanol (GORZ) and elucidated the molecular mechanisms involved in its inhibition of behavioral test-induced anxiety. Behavioral tests were conducted on day 13, and mice were subjected to 30 min of acute restraint stress treatment (ARST) before sacrifice on day 16. In other group, behavioral tests were conducted on day 13 and 14 after ARST. 0.5{\%} GORZ significantly weakened the effect of behavioral stress, but not the effect of strong ARST. GORZ downregulated ARST-induced cFos levels in the cerebral cortex. In conclusion, GORZ has potential ant-anxiety effect in the treatment of weak behavioral test-induced stress.",
    keywords = "Anxiety, Behavioral tests, cFos",
    author = "Salina Akter and Hiroyuki Sasaki and Yuko Ikeda and Hiroki Miyakawa and Shigenobu Shibata",
    year = "2018",
    month = "1",
    day = "1",
    doi = "10.1016/j.jphs.2018.06.003",
    language = "English",
    journal = "Journal of Pharmacological Sciences",
    issn = "1347-8613",
    publisher = "Japanese Pharmacological Society",

    }

    TY - JOUR

    T1 - γ-oryzanol ameliorates the acute stress induced by behavioral anxiety testing in mice

    AU - Akter, Salina

    AU - Sasaki, Hiroyuki

    AU - Ikeda, Yuko

    AU - Miyakawa, Hiroki

    AU - Shibata, Shigenobu

    PY - 2018/1/1

    Y1 - 2018/1/1

    N2 - We evaluated the anxiolytic effect of γ-oryzanol (GORZ) and elucidated the molecular mechanisms involved in its inhibition of behavioral test-induced anxiety. Behavioral tests were conducted on day 13, and mice were subjected to 30 min of acute restraint stress treatment (ARST) before sacrifice on day 16. In other group, behavioral tests were conducted on day 13 and 14 after ARST. 0.5% GORZ significantly weakened the effect of behavioral stress, but not the effect of strong ARST. GORZ downregulated ARST-induced cFos levels in the cerebral cortex. In conclusion, GORZ has potential ant-anxiety effect in the treatment of weak behavioral test-induced stress.

    AB - We evaluated the anxiolytic effect of γ-oryzanol (GORZ) and elucidated the molecular mechanisms involved in its inhibition of behavioral test-induced anxiety. Behavioral tests were conducted on day 13, and mice were subjected to 30 min of acute restraint stress treatment (ARST) before sacrifice on day 16. In other group, behavioral tests were conducted on day 13 and 14 after ARST. 0.5% GORZ significantly weakened the effect of behavioral stress, but not the effect of strong ARST. GORZ downregulated ARST-induced cFos levels in the cerebral cortex. In conclusion, GORZ has potential ant-anxiety effect in the treatment of weak behavioral test-induced stress.

    KW - Anxiety

    KW - Behavioral tests

    KW - cFos

    UR - http://www.scopus.com/inward/record.url?scp=85054698529&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85054698529&partnerID=8YFLogxK

    U2 - 10.1016/j.jphs.2018.06.003

    DO - 10.1016/j.jphs.2018.06.003

    M3 - Article

    C2 - 30322802

    AN - SCOPUS:85054698529

    JO - Journal of Pharmacological Sciences

    JF - Journal of Pharmacological Sciences

    SN - 1347-8613

    ER -